France IVD Market is expected to garner $4,509 Million by 2023 End

"Immunodiagnostics occupied the highest share of the market in 2016 and is expected to maintain the lead during the forecast period due to increase in prevalence of infectious diseases and chronic diseases."

According to a new report published by Allied Market Research, titled, "France IVD Market by Product Type, Techniques, Application and End-Users: Global Opportunity Analysis and Industry Forecast, 2017-2023.",France IVD market was valued at $2,943 million in 2016, and is projected to reach at $4,509 million by 2023, growing at a CAGR of 6.2% from 2017 to 2023.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/3600

IVD techniques include, but are not limited to, medical specimens such as blood, urine, feces, and fluids derived from the body to detect diseases, conditions, and infections. IVD testing is also used in stand-alone and hospital-based laboratories. Technologies such as polymerase chain reaction, microarray technology, sequencing technology and mass spectrometry are used in biological samples.

Based on product types, the reagents segment held the highest market share in 2016, due to R&D in chemical science and invention of new chemical reagents for IVD technique.

Based on techniques, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of carcinogenic disease.

Based on application, the infectious diseases segment contributed the highest market share in 2016, due to rapid increase in infectious diseases and rise in awareness about health.

Based on end users, in 2016, the standalone laboratory segment captured the highest market share. This is mainly attributed to the fact that standalone laboratories are well equipped with high-tech infrastructure to perform difficult IVD tests with high precision over hospitals.

Increase in Prevalence of Infectious Diseases

The IVD market in France is in its growth phase due to increase in incidences of infectious diseases such as tuberculosis, HIV, AIDS, malaria, rabies, ebola virus, and pertussis. Due to increase in infectious disease there is rise in the demand for IVD market, for instance, 357 generic infectious diseases are spread of which 225 is contributed by France.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/3600

Rising Aging Population

The France IVD market is on an increase due to increase in geriatric population. The number in volume of chronic and infectious diseases increases as the aging population increases. For instance, according to the European commission about 16% of the population are above 65-year-old, which is greater in number in comparison of other countries such as Ireland (11%), and Netherlands (13%). Which shows that Europe has larger percent of aging population which is anticipated to increase by2050.The demographic number of people aged 85 and older is on a rise, increasing from about 1 million people in the mid-2000s to about 2.5 million in 2030.

Technological Advancement in IVD

Advancement in technology of IVD products such as, minimally invasive techniques, digital pathology solutions, selfcare care tests such as glucose, pregnancy, and others, is on an increase. This factor fuels the growth of the France IVD market.

Key Benefits

• The study provides an in-depth analysis of the France IVD market with current trends and future estimations to elucidate the imminent investment pockets
• The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities
• Extensive analysis by technology and application helps understand various trends and prevailing opportunities in the respective market
• Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which predict the competitive outlook of the France IVD market.

Key Findings of the France IVD Market

• The immunodiagnostics segment dominated the market in 2016, and is projected to grow at the 6.4% CAGR.
• The immunodiagnostics segment accounted for the highest share in 2016.
• The standalone laboratory segment accounted for the highest share in 2016.
• France is expected to grow at the highest CAGR in the IVD market.

The major players profiled in the France IVD market are Thermo Fisher Scientific Inc., Alere Inc., Biomerieux, Danaher Corporation, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Bio-Rad Laboratories, Bayer AG, Sysmex Corporation, and Johnson & Johnson.

For More Details on this Report visit @ https://www.alliedmarketresearch.com/france-ivd-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.